Net loss attributable to common stockholders was $10.4 million, or $0.10 per diluted share, compared to a $4.7 million loss in Q1 2025. Total revenues were $185.1 million, slightly up from $184.5 million in the prior year period. Pro forma RevPAR increased 0.2% to $126.57, with ADR rising 1.5% to $176.85. Adjusted FFO decreased to $25.5 million ($0.21 per share) from $27.4 million ($0.22 per share) in Q1 2025. The company entered an agreement to sell two hotels in Arlington, TX for $19 million at a 5.0% capitalization rate. Repurchased 1.4 million common shares during the quarter for $6.0 million.